Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation (Q40735093)

23 September 2017

Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation (English)

1 reference

23 September 2017

1 reference

Yang Xia

1

1 reference

23 September 2017

Hong Y Wen

series ordinal

2

1 reference

23 September 2017

Rodney E Kellems

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

30 April 2002

1 reference

Journal of Biological Chemistry

23 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

277

1 reference

23 September 2017

24601-24608

1 reference

23 September 2017

27

1 reference

The plasminogen activator/plasmin system

23 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Cell-associated plasminogen activation: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

The urokinase receptor and regulation of cell surface plasminogen activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

The plasminogen-plasmin system in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Plasminogen Activation by Receptor-Bound Urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Association of TGF-beta signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: role of PKC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

The human placental renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

The uteroplacental renin-angiotensin system: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Mechanism of control of trophoblast invasion in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Calcineurin signaling and muscle remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201369200

21 January 2018

Identifiers

DOI

10.1074/JBC.M201369200

1 reference

23 September 2017

1 reference